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Our current understanding of DNA’s role in providing instructions for the genetic code 
have led to an abundance of applications in daily life including forensic testing, genetic screening, 
and research. Over the past two centuries, deoxyribose nucleic acid (DNA) has transitioned from 
an obscure molecule with unknown structure and function to the very foundation of modern 
biology. From Gregor Mendel’s pea plants to the Griffith experiment to Avery, McCarty, and 
Macleod to Hershey and Chase to Watson and Crick and all of the scientists in between, the story 
of DNA has provided researchers with the tools to understand organisms and many types of 
viruses.  
DNA and ribonucleic acid (RNA) make up the two major classes of nucleic acids: both are 
polymers that are composed of monomeric nucleotide units. Each nucleotide consists of three 
molecular fragments; deoxyribose or ribose sugar molecules in DNA and RNA respectively, a 
phosphate group, and a nitrogenous base (Figure 1). The four nitrogenous bases in nucleic acids 
are adenine (A), cytosine (C), guanine (G), and thymine (T). In RNA, uracil (U) takes place of 
thymine (T). Nitrogenous bases are bound to a 
sugar molecule via a B-glycosyl linkage. Consecutive 
linkages make up the sugar phosphate backbone in 
nucleic acids. Each monomeric unit in the backbone 
consists of a 5’ attachment of phosphate groups on 
a sugar molecule and its corresponding 3’ ester 
linkage to the carbon of an adjacent nucleotide. In 
DNA, two sugar phosphate backbones run antiparallel to one another and twist to form a double 
Figure 1: Structure of DNA (Minchin et al., 2019) 
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helix structure bound by hydrogen bonds between a purine and a pyrimidine1. Specific base 
pairing between guanine (G) and cytosine (C) as well as adenine (A) and thymine (T)/ uracil (U) is 
essential for life and the structure of nucleic acids.  
Found inside the nucleus of eukaryotic cells in the form of chromatin or heterochromatin, 
DNA acts to provide a long-term storage facility of genetic information and is able to copy itself 
via replication. Other DNA molecules found within the eukaryotic genome may also serve other 
structural functions, regulate gene expression, and provide the genetic information necessary for 
the transcription of messenger RNA (mRNA)2 . Transcription begins when RNA polymerase binds 
to a promoter region of DNA: this allows for elongation of the mRNA strand (Figure 2). When the 
RNA polymerase recognizes and transcribes 
the terminator sequence on DNA, the mRNA 
molecule is transported to the cytoplasm by 
ribosomal RNA (rRNA). Inside the cytoplasm, 
ribosomes bind to the newly synthesized 
mRNA strand and recruit transfer RNA (tRNA) to bind at a site- specific codon region. The amino 
acids bound to each molecule of tRNA make up a finalized protein which may undergo further 
modifications in a neighboring cell organelle. This process is often referred to as the central 
dogma of life.  
Unlike DNA, RNA molecules are easier to break down and do not have a stable secondary 
structure2. The 2’ hydroxyl group on ribose sugar results different behavior in chemical 
environments compared to the 2’ hydrogen in deoxyribose sugar.  However, the single stranded 
nature of RNA allows for a more dynamic range of possible 3-D structures such as hairpin loops, 
Figure 2: Transcription (Minchin et al., 2019) 
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multiloops, or internal loops. Due to the diversity in shape of RNA, it’s function serves many 
essential purposes including ligand binding, catalysis of chemical reactions, protein synthesis and 
recognition, splicing, and other chemical modifications3. The activity of RNA is extremely 
dependent on its surrounding chemical environment- understanding this structure and its vital 
role played in the natural world is desired by researchers.  
One way that RNA directly interacts with proteins involves the formation of 
ribonucleoprotein complexes (RNP) which can contain one or more protein subunits bound to 
one or more RNA molecules3. Research of RNA interactions is important as it provides 
information on how conformational changes initiate many essential molecular events. One 
example of how researchers are currently studying RNPs can be seen in Structural Changes of 
RNA in Complex with Proteins in the SRP where the relationship between RNA and protein binding 
was investigated. Through NMR, cryo-electron microscopy, and X-ray crystallography, 
researchers learned that RNA and protein binding can be classified as specific, protein specific, 
or non- specific3. 
RNA is also being used in gene therapy research. In a 2019 study published in Nature, 
Zhong and colleagues engineered a class of ribozymes that function to produce RNA switches 
that can cleave mRNA in a tightly regulated environment4. Without the addition of various 
protein complexes, reactions between RNA switches and mRNA could be manipulated and 
monitored more efficiently to monitor protein expression from an mRNA starting point. The 
removal of confounding variables in this study allowed for a more comprehensive understanding 
of RNA interactions in conjunction with gene-therapy techniques. It was reported that RNA 
switches were much safer than other gene-therapy techniques offered in healthcare.  
Holli Corbo (hfc278)  Hull Group 
 
4 
Nucleic acids may also make up some of the genetic material in viruses. For example, 
COVID-19 contains genetic material in the form of RNA. RNA viruses can be classified according 
to sense or polarity of their RNA into negative-sense and positive-sense. Positive- sense RNA 
viruses have their genetic information in the form of mRNA. Upon infection by this type of virus, 
the host can immediately translate the viral material into viral proteins. Negative-sense RNA 
contains genetic information complimentary to mRNA and must be converted into positive-sense 
by an RNA polymerase. The coronavirus (CoV) family is characterized by an enveloped positive-
sense single-stranded RNA virus. Coronavirus can specifically bind to entry receptors in a host 
through their spike proteins. Expression of proteins encoded for by the virus results in a 
respiratory immune response.   
Nucleic acids are generally thought of as the blueprint to all life because they contain 
complex instructions for how organisms develop and replicate themselves. Nucleic acids can fold 
into complex structures depending on their chemical environment and adjust their function in 
the cell accordingly. However, the synthetic production of nucleic acids is a fairly new concept 
emerging from the explosion of technology in the 20th and 21st century. The generation of 
oligonucleotides with relatively non-biological functions began generation of nucleic acids invitro 
and amplification for specific use. Aptamers are nucleic acid molecules that can be extracted 
naturally from the environment or synthetically made: they can bind to a wide range of potential 
targets. In the following section we will examine the use of aptamers in nature and in research 
and identify the strengths and weaknesses of this class of biosensor.  
  




Aptamers are short single-stranded oligonucleotide molecules that can bind at site- 
specific sequences of a desired target. In the late 20th century, Craig Turek and Larry Gold 
published a paper describing a process called Systematic Evolution of Ligands by Exponential 
Enrichment (SELEX), an aptamer selection approach5. Depending on the sequence of the 
aptamer, the ligand could be small molecules including peptides, cells, tissues, and proteins. 
Aptamer recognition of small molecule ligands results in a structural change at the tertiary 
structure level, an ideal characteristic of nucleic acid aptamers as molecule shape defines 
molecule function. SELEX, involves a library of single-stranded (ssDNA) molecules that produce 
ssDNA molecules or ssRNA molecules that can specifically bind to ligands (Figure 3). The original 
ssDNA library is composed of random 
sequences of oligonucleotides marked with 
primers on both the 3’ and 5’ end. After 
exposure to the target ligand, sequences 
that do not bind are removed from the 
library. On the other hand, sequences that do bind the molecule of interest are amplified by PCR 
to create double stranded DNA templates for use in-vitro synthesis of a desired DNA or RNA that 
serve as aptamers. The amplification process is repeated until the aptamer population is 
prepared for species with a target function6.  
 Aptamers are often compared to antibodies in regards to their biosensing abilities, but 
aptamers have been shown to display the greatest binding affinity, specifically in the pico-molar 
range, to their target molecules and are extremely stable7. To elaborate, aptamers can be 
Figure 3: Selection of Aptamers (Maier et al., 2016) 
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developed for almost any analyte and are smaller in size compared to antibodies, a preferrable 
characteristic when working in-vitro. For example, Chen and colleagues established a class of 
fluorescence-based aptamer biosensors that present with high detection of a target molecule 
HBC8. The fluorescence of HBC was enhanced 3000 fold when bound to aptamer D11 with 
reduced Mg2+ sensitivity and multiple rounds of optimization.  This type of biosensor offered high 
sensitivity to HBC and real-time detection of the target. One disadvantage of aptamers is that 
SELEX takes several months to complete and can be very expensive compared to the simple 
synthesis of antibodies for a target of interest. However, SELEX and counter- SELEX yields 
aptamers that are extremely precise and do not bind to derivatives of their target molecule.  
In consideration of another comparison category, aptamers can be stored for long periods 
of time as they are able to regain initial target binding sites after denaturation. In strike contrast 
to aptamers, antibody fragments cannot conserve their binding abilities once they have been 
denatured or compromised by things like enzyme activity, heat, or cleavage. Antibody fragments 
cannot be stored for a long period of time and have slight rejuvenation abilities7. Aptamers can 
be developed in non-conventional environments, allowing for more flexibility in procedure 
compared to their competing biosensor that requires compatible denaturing solvents and 
animals with an immune response7. The production of antibodies involves immunization of 
animals and blind- reliance on their immune systems depending on whether or not that animal 
can illicit an immune response in conjunction with researcher expectations. Several factors can 
impact this process including lack of antibody produced once extracted from the animal, complex 
immunogen preparations, and careful delivery of the antigen itself. Relying on the immune 
system to produce an antibody of interest for use in biosensing not as reliable as the SELEX 
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approach for aptamers and introduces more confounding variables7. Because aptamers have a 
larger range of target potential compared to antibodies, this class of biosensor play an 
advantageous role in clinical diagnostics and as therapeutic agents9.  
Aptamers exist naturally as ligand-binding elements of riboswitches, a regulatory element 
in mRNA molecules10. RNA molecules can act as receptors for other small molecules and 
modulate stages of gene expression. These small molecule metabolites can bind to regions of 
RNA, called riboswitches that affect transcription, splicing, or translation11. It is known that 
thiamine pyrophosphate, flavin mononucleotide, cobalamin, SAM, purines, glucosamine 6-
phosphate, lysine, and glycine bind to riboswitches and every vitamin cofactor may bind to an 
RNA riboswitch. For example, the thiM riboswitch controls transcription of RNA. This small 
molecule can stabilize and mask or unmask functional RNA sequences: as ligand binding occurs 
on the thiM riboswitch, masking of a transcriptional anti-terminator region may take place to 
reveal transcriptional terminators11. Along with that, binding of a ligand to this riboswitch may 
hide ribosomal binding sites in order to prevent mRNA molecules from binding or associating 
with the ribosome. Some plants and fungi utilize thiM alternate splicing mechanisms of mRNA to 
consequentially affect protein expression. In analysis of the binding pattern of thiM riboswitch 
with thiamine pyrophosphate, pi stacking of thiamine and coordination around a Mg2+ ion takes 
place. To illustrate another example, the GlmS riboswitch binds to glucosamine-6-phosphate 
(G6P), acting as a cofactor for self-cleavage. The amine group of G6P acts as a Bronsted Acid 
allowing the GlmS riboswitch to protonate a leaving group during hydrolysis. Purines can also 
activate riboswitches within mRNAs that code for enzymes used in purine biosynthesis and 
transport. When more than one riboswitch is available in a nucleic acid transcript, they are all 
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able to sophisticatedly work together to control gene expression. All in all, riboswitches provide 
feedback control to biosynthetic machineries that synthesize the small metabolites they bind.  
Aptamers selected from a random library of single-stranded DNA are found to imitate 
their natural equivalent, the riboswitches in both binding affinity and specificity. Emerging as 
potential targets for drug development and ensuring food safety and environment monitoring, 
aptamers are promising chemical elements in research. For example, the synthesis of Pegaptanib, 
a drug used in treatment of macular degeneration was the first aptamer approved for therapeutic 
use in humans12.  Researchers began by first creating a DNA oligonucleotide library with a variable 
region followed by an T7- RNA polymerase promoter. The desired target, vascular endothelial 
growth factor (VEGF), was selected for based on its role as a regulator in pathological 
angiogenesis and inflammatory conditions like arthritis12. VEGF molecule is primarily responsible 
for restoring blood supply to tissues when deprived of oxygen or proper blood circulation. 
However, overexpression of VEGF is harmful in macular degeneration (AMD) causing an 
abnormal amount of blood vessels under the retina. In the attempt to design a drug that could 
treat this disease, the SELEX approach for aptamer selection and optimalization with 2’-F 
substitutions yielded the aptamer Pegaptanib12. Aptamer and target mixtures invitro were 
performed to trigger the growth of blood vessels. Pegaptanib could bind to VEGF with higher 
affinity than any of its competing aptamers, inhibiting the activity of the target molecule to bind 
to receptors and result in overexpression. Administered through injection, clinical trials of 
Pegaptanib showed decrease in vision loss and was eventually approved by the FDA in 200412.  
In light of the recent coronavirus, SARS-CoV-2 pandemic, aptamers as biological probes 
reveal promising biosensors for diagnosing and treating coronavirus13. Aptamers can detect viral 
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infection markers within the body including virus-stricken genes, antibodies, and proteins. With 
the highly sensitive nature of aptamers, they can detect and differentiate between infected or 
non-infected cells. Although Pegaptanib is the only aptamer- based drug approved for use by the 
FDA, there is hope that a similar type of drug could be designed to treat COVID-19. Researchers 
have found that the Helicase, a nucleic acid enzyme that binds and remodels DNA or protein 
complexes, may be a potent target for development in coronavirus medicinal aptamers13. 
Helicase as a target molecule for aptamer development was previously examined by Shum and 
colleagues in 2008. All aptamers selected from SELEX selection stimulated ATPase activate of the 
coronavirus helicase. Non-G-quadruplex aptamers with low Km values showed inhibition of 
helicase activities and were modified to increase stability invitro. The selected aptamers are 
undergoing further development to potentially inhibit SARS-CoV replication14.  
Biochemistry 
The specific-binding nature of aptamers have allowed for developments in research 
focusing on chemical probing. Synthetically synthesized chemical probes allow researchers to 
monitor site-specific interactions of RNA aptamers. Chemical probes can be used to monitor 
aptamer interactions though imaging of live cellular RNAs such as chemical modifications, 
splicing, degradation, or translocation. Probes are especially useful in real-time analysis of 
optimal drug doses for patients, glucose activity in diabetic patients, or antibiotic effectiveness. 
For example, Ferguson and colleagues utilized a microfluidic electrochemical detector (MEDIC) 
in vivo while exchanging probes throughout the process to monitor a chemotherapeutic drug and 
an antibiotic in live rats as well as human blood15. MEDIC was found to achieve quantitative 
measurements of molecules circulating in blood in living animals. Researchers first attached a 
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chip to the patient’s blood stream to measure drug concentration and followed this step by 
connecting an aptamer probe to a gold electrode. Binding of the target by the aptamer in the 
electrode introduced a conformational change in the aptamer-probe complex that increased the 
rate of electron transfer between two electrodes. Measurements were taken of current after the 
3D structure change and reported as an electrochemical signal15.  
 Aptamers can also be monitored by use of photoacoustic (PA) probes based on DNA 
aptamers16. The PA probe designed by Jingjing Zhang’s team combined molecular recognition 
technology and a PA signal or shift in an absorbance peak upon target-binding to monitor 
aptamers. Thrombin, a molecule that plays a role in coagulation, was chosen as the target: upon 
aptamer binding to the target, a duplex structure was formed. Further investigation was carried 
out using three different control proteins as a target for the DNA probe but concluded that the 
original probe retained its binding specificity to thrombin even in complex environments. The 
aptamer based PA probe showed significant change in signals toward thrombin allowing for the 
first activatable PA probe to be used in molecular imaging in living animals16.   
 As demonstrated above, there are a variety of ways to monitor aptamer activity through 
chemical probes, but the most common method involves fluorescence-based aptamer probes. 
Aptamer biosensors can be divided into two categories according to Wang: those that use 
fluorescence labels and those that employ label-free methods17. Analysis of aptamer activity 
through fluorescent probes is possible because the structural changes of aptamers upon target 
biding can affect the fluorescence of a dye or change the energy transfer between two dyes 
before and after binding. The signal change in fluorescence reflects the binding process of 
aptamers which allows for quantitative measurement of a target molecules concentration. 
Holli Corbo (hfc278)  Hull Group 
 
11 
Target molecules that respond to an aptamer and reveal a change in fluorescence include 
proteins, small molecules, and metal ions. Aptamer based biosensors in modulation with 
fluorescent probes and dyes is a promising area of research in the field of disease diagnosis.  
 Although fluorescent RNA aptamers have been used to monitor an abundance of cellular 
RNA species, there are limitations in availability of dye and low brightness8.  In 2019 a group of 
researchers discovered Peppers, a promising fluorescent RNA aptamer. Probe synthesis achieved 
(4-((2-hydroxyethyl)(methyl)amino)-benzylidene)-cyanophenyl-acetonitrile (HBC), a green 
fluorescent protein (GFP) fluorophore like dye. This aromatic acetonitrile is an electron acceptor 
that maintains rigidity and molecular structure upon binding with Peppers. Along with that, HBC 
was found to be non-fluorescent in solution, but fluoresces upon binding to Peppers aptamer8 
(Figure 4). This was useful in real time tracking of RNA activity. Specifically, live cells expressing 
Pepper exhibited green fluorescence when 
incubated with HBC. High binding affinity 
and thermal stability of the HBC probe are 
advantageous compared to previously 
developed fluorescent probes. It was found 
that the Pepper-HBC complex was not affected when fused to the ends of naturally occurring 
RNAs or with a terminal stem loop. In particular, Pepper was able to detect RNA polymerase and 
transcription of mRNAs while showing significant fluorescence in the endoplasmic reticulum and 
integral proteins of the plasma membrane8. HBC-like fluorophores showed promising results to 
researchers leading Chen’s team to identify 7 other molecules that fluoresced from 485nm to 
620nm. Chen’s team found that translation of mRNA into protein was governed by normal 
Figure 4: Pepper-HBC Complex (Chen et al., 2019) 
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enzyme kinetics but with marked heterogeneity. Along with that, Peppers can be used to image 
loci with CRISPR display for protein tracking.  
 Another fluorescent-based aptamer that monitors RNA transcription in cells is Corn. Corn 
can bind and induce fluorescence of 3,5-difluoro-4-hydroxybenzylidene-imidaxolinone-2-oxime 
(DFHO),  a fluorophore that acts like red fluorescent protein (RFP)18. Corn was developed to 
quantify transcription of RNA by RNA polymerase 3 in cells. The Corn-DFHO structure was found 
to be a quasimetric homodimer that captures DFHO at a promoter-interface. Researchers were 
able to quantify RNA polymerase 3 trajectories through the photostable RNA- fluorophore 
complex signals that revealed mTOR inhibition, a protein kinase. 
  






Figure 5: Retrosynthesis Analysis of (4-((2-hydroxyethyl)(methyl)amino)-benzylidene) cyanophenyl-acetonitrile 
Considering the ambiguity of the target molecule, (4-((2-hydroxyethyl)(methyl)amino)-
benzylidene)-cyanophenyl-acetonitrile, we envisioned this multiple step retrosynthesis pathway 
to achieve the probe of interest (Figure 5).  In the first step of retrosynthesis, the target molecule 
can be disconnected at the location of the double bond, revealing a cyano-compound and an 
aldehyde as potential starting material. The separation of the double bond reveals that the two 
starting material products can be used together in the Knoevenagel Condensation reaction. Since 
the cyano-compound 4-(cyanomethyl)benzonitrile can be obtained commercially, no further 
retrosynthesis was necessary. However, the aldehyde compound, 4-
((2hydroxyethyl)(methyl)amino)benzaldehyde must be synthesized in the lab. Retrosynthesis 
analysis of the aldehyde revealed starting material of a hydroxyalkyl group and 4-
(methylamino)benzaldehyde. These two compounds can be used to form the non-commercially 
available aldehyde by an N-alkylation reaction. The aldehyde can further be broken down into 
starting material 4-(methylamino)benzoic acid.  





Figure 6: Synthesis of (4-((2-hydroxyethyl)(methyl)amino)-benzylidene) (6) 
In the first step of the synthesis pathway, 4-(methylamino)benzoic acid (1) underwent 
esterification by thionyl chloride to yield methyl 4-(methylamino)benzoate (2). The carboxylic 
acid was mixed with methanol and 1.5 equivalents of SOCl2. To achieve methyl 4-((2-𝜆1-
silyl)oxy)ethyl)(methyl)amino)benzoate (3), N-alkylation was performed on the amino group of 
compound 2. Isolation of compound 3 allowed for further reduction of the ester group by 1 
equivalent of lithium aluminum hydride (LAH) to get the aldehyde 4-((2-𝜆1-
silyl)oxy)ethyl)(methyl)amino)benzaldehyde (4). Because this aldehyde is not commercially 
available, it was necessary to synthesize compound 4 in order to perform the Knoevenagel 
Condensation reaction (KC).  The conditions of the KC reaction should proceed as follows: 
reaction workup at 50°C for 48 hours, dropwise addition of strong acid followed by filtration and 
recrystallization from acetic acid. The catalytic base intended for use in this experiment is 1,8-
Diazabicyclo(5.4.0)undec-7-ene (DBU) because it allows for the thermodynamically unfavored KC 
reaction to take place rather than the fast reaction. The last proposed step of the synthesis 
pathway involves deprotection of the alcohol to generate the target molecule (HBC).   




General Experimental Procedures:  
Reagents were handled in a fume hood. Column chromatography was performed with 
silica gel from SiliCycle (40-63 μm) with a column mixed as a slurry with the eluent and was 
packed, rinsed, and run under air pressure. Analytical thin-layer chromatography (TLC) was 
performed on precoated glass silica gel plates (by EMD Chemicals Inc.) with F-254 indicator with 
visualization by short wave (254 nm) ultraviolet light. Distillations were performed using a 3 cm 
short-path column under reduced pressure. 
Instrumentation:  
1 H and 13C NMR spectra were recorded on Varian Unity 500 MHz (125 MHz for 13C) 
spectrometer. Spectra were referenced to the residual solvent peak of CDCl3 unless otherwise 
noted. Chemical shifts were reported in parts per million and multiplicities are as indicated: s 
(singlet,) d (doublet,) t (triplet,) q (quartet,) p (pentet,) m (multiplet,) and br (broad). Coupling 
constants, J, are reported in Hertz and integration is provided, along with assignments, as 
indicated. Gas Chromatography (GC) was performed on a Shimadzu GC-2010 Plus gas 
chromatograph with SHRXI–MS- 15m x 0.25 mm x 0.25 μm column with nitrogen carrier gas and 
a flame ionization detector (FID). The glove box, MBraun LABmaster sp, was maintained under 
nitrogen atmosphere.  
Materials:  
Solvents used for extraction and column chromatography were reagent grade and used 
as received. Reaction solvents tetrahydrofuran (Fisher, unstabilized HPLC ACS grade), toluene 
(Fisher, optima ACS grade), 1,4-dioxane (Fisher, certified ACS), acetonitrile (Fisher, HPLC grade), 
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and hexanes (Fisher, ACS HPLC grade) were dried on a Pure Process Technology Glass Contour 
Solvent Purification System using activated Stainless-Steel columns while following 
manufacturer’s recommendations for solvent preparation and dispensation unless otherwise 
noted. Unless otherwise shown, all noncommercial substrates were prepared according to the 
known literature procedures. 
Experimental Procedures 
Synthesis of methyl-4-(methylamino)benzoate (2): 
To a solution of 4-(methylamino)benzoic acid (0.500 g, 1 Eq, 3.31 mmol) in methanol 
(20mL) was added thionyl chloride (590 mg, 362 µL, 1.5 Eq, 4.96 mmol) dropwise at 0°C. The 
reaction mixture was warmed to room temperature and stirred at 65°C for 3 hours. The reaction 
was allowed to cool to room temperature and was quenched with 𝑁𝑎𝐻𝐶𝑂3 in an ice bath at 0°C 
and extracted with ethyl acetate (3 x 200mL). The organic layers were dried over 𝑁𝑎2𝑆𝑂4 and 
concentrated to give methyl-4-(methylamino)benzoate (Figure 6 (2)). Product mass was 
determined to be 0.4145g (76% yield) as a yellow solid, which was used to next step without 
further purification.  
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